Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti‐bacterials

In light of the pending antibiotic resistance crisis, we need to go back to nature and search for novel anti‐bacterial compounds.[Image: see text]

Detalles Bibliográficos
Autores principales: Hegemann, Julian D, Birkelbach, Joy, Walesch, Sebastian, Müller, Rolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Science & Society
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827545/
https://www.ncbi.nlm.nih.gov/pubmed/36541849
http://dx.doi.org/10.15252/embr.202256184
_version_ 1784867077392171008
author Hegemann, Julian D
Birkelbach, Joy
Walesch, Sebastian
Müller, Rolf
author_facet Hegemann, Julian D
Birkelbach, Joy
Walesch, Sebastian
Müller, Rolf
author_sort Hegemann, Julian D
collection PubMed
description In light of the pending antibiotic resistance crisis, we need to go back to nature and search for novel anti‐bacterial compounds.[Image: see text]
format Online
Article
Text
id pubmed-9827545
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98275452023-01-11 Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti‐bacterials Hegemann, Julian D Birkelbach, Joy Walesch, Sebastian Müller, Rolf EMBO Rep Science & Society In light of the pending antibiotic resistance crisis, we need to go back to nature and search for novel anti‐bacterial compounds.[Image: see text] John Wiley and Sons Inc. 2022-12-21 /pmc/articles/PMC9827545/ /pubmed/36541849 http://dx.doi.org/10.15252/embr.202256184 Text en © 2022 The Authors. Published under the terms of the CC BY NC ND 4.0 license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Science & Society
Hegemann, Julian D
Birkelbach, Joy
Walesch, Sebastian
Müller, Rolf
Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti‐bacterials
title Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti‐bacterials
title_full Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti‐bacterials
title_fullStr Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti‐bacterials
title_full_unstemmed Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti‐bacterials
title_short Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti‐bacterials
title_sort current developments in antibiotic discovery: global microbial diversity as a source for evolutionary optimized anti‐bacterials
topic Science & Society
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827545/
https://www.ncbi.nlm.nih.gov/pubmed/36541849
http://dx.doi.org/10.15252/embr.202256184
work_keys_str_mv AT hegemannjuliand currentdevelopmentsinantibioticdiscoveryglobalmicrobialdiversityasasourceforevolutionaryoptimizedantibacterials
AT birkelbachjoy currentdevelopmentsinantibioticdiscoveryglobalmicrobialdiversityasasourceforevolutionaryoptimizedantibacterials
AT waleschsebastian currentdevelopmentsinantibioticdiscoveryglobalmicrobialdiversityasasourceforevolutionaryoptimizedantibacterials
AT mullerrolf currentdevelopmentsinantibioticdiscoveryglobalmicrobialdiversityasasourceforevolutionaryoptimizedantibacterials

Ejemplares similares